Importantly, proteins involved in metabolic diseases such as HSD17B13 (ref. 7) (an orthologue of the Drosophila HSD17B11) may utilize the late ER-to-LD targeting pathway, highlighting the importance of understanding these targeting mechanisms for possible therapeutics. This evidence concerns the gene HSD17B13 and metabolic disease.